Quantum BioPharma (NASDAQ: QNTM) Is Advancing a First-in-Class Multiple Sclerosis Drug — and the Phase 2 Clock Just Started Mar 30, 2026Quantum BioPharma Ltd. (NASDAQ: QNTM)... read more
